ProShares Ultra Nasdaq Biotechnology Rating $56.56 +0.00 (+0.01%) Closing price 03:59 PM EasternExtended Trading$56.58 +0.02 (+0.03%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BIB Aggregate RatingModerate Buy 2.69Holdings in BIB have an aggregate rating of Moderate Buy based on 343 analyst ratings issued in the past year covering 19 companies (37.0% of the portfolio).BIB Aggregate Price Target$56.600.07% UpsideHigh Prediction$56.60Average Prediction$56.60Low Prediction$56.60Holdings in BIB have an aggregate price target of $56.60 and a range of $56.60 to $56.60 covering 19 companies (37.0% of the portfolio).BIB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 BIB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.60%GILDGilead Sciences$110.86-1.5%4.9334 of 5 stars2.89$116.04 4.7%27Positive NewsAnalyst Forecast4.50%AMGNAmgen$273.08-0.5%4.6691 of 5 stars2.24$304.43 11.5%21Positive News3.96%REGNRegeneron Pharmaceuticals$575.06+0.4%4.7025 of 5 stars2.82$817.67 42.2%28Positive NewsShort Interest ↑3.95%VRTXVertex Pharmaceuticals$391.36-0.5%4.8996 of 5 stars2.57$496.05 26.7%28Positive News3.30%ALNYAlnylam Pharmaceuticals$461.24+0.0%3.7763 of 5 stars2.86$426.85 -7.5%28Positive NewsAnalyst Forecast3.05%AZNAstraZeneca$77.56-0.6%2.9373 of 5 stars2.75$86.00 10.9%4Positive NewsShort Interest ↑Analyst Revision1.53%INSMInsmed$144.75+1.1%3.3174 of 5 stars2.94$139.86 -3.4%17Positive NewsInsider Trade1.33%ARGXargenex$752.32-0.6%3.9623 of 5 stars3.04$784.32 4.3%23Analyst Downgrade1.30%BIIBBiogen$143.68+0.3%4.6913 of 5 stars2.32$181.65 26.4%31Positive News1.24%SMMTSummit Therapeutics$18.12-4.3%3.3658 of 5 stars2.65$33.79 86.5%17Positive NewsAnalyst Forecast1.05%INCYIncyte$83.90+0.9%4.7228 of 5 stars2.33$82.53 -1.6%18Positive NewsAnalyst DowngradeShort Interest ↓1.03%ILMNIllumina$101.48+0.6%4.7165 of 5 stars2.21$123.06 21.3%19Positive News0.98%RPRXRoyalty Pharma$35.42+0.8%4.859 of 5 stars3.33$48.00 35.5%3Positive NewsAnalyst Downgrade0.92%SNYSanofi$46.86+0.5%3.9572 of 5 stars3.20$62.67 33.7%100.90%UTHRUnited Therapeutics$397.97-1.3%4.8 of 5 stars2.69$438.85 10.3%13Positive NewsInsider Trade0.86%TEMTempus AI$87.04+2.2%2.0229 of 5 stars2.54$70.17 -19.4%130.86%NBIXNeurocrine Biosciences$140.90+0.3%4.7678 of 5 stars2.85$160.26 13.7%20Positive News0.85%MEDPMedpace$490.77-1.1%4.3068 of 5 stars1.94$422.27 -14.0%16Positive News0.83%ONCBeOne Medicines$327.20-1.5%1.7808 of 5 stars3.00$330.89 1.1%7 This page (NASDAQ:BIB) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIB Stock Alerts